AURA: Aura Biosciences, Inc. Stock

by  •  • Comments Off on AURA: Aura Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 262.65
Enterprise Value ($M) 230.96
Book Value ($M) 151.97
Book Value / Share 3.02
Price / Book 1.73
NCAV ($M) 130.09
NCAV / Share 2.59
Price / NCAV 2.02

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 10.77
Current Ratio 10.77

Balance Sheet (mrq) ($M)
Current Assets 160.62
Assets 182.50
Liabilities 30.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -96.12
Net Income -86.92
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -79.81
Cash from Investing 68.82
Cash from Financing 1.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-11 13G Suvretta Capital Management, Llc 6.10
02-14 13G/A Eventide Asset Management, Llc 8.17 -29.68
01-03 13G Long Focus Capital Management, Llc 5.70
11-14 13G/A Lundbeckfond Invest A/S 3.50 -13.26
11-14 13G/A Citadel Advisors Llc 0.10
11-12 13G/A Adage Capital Management, L.P. 9.84
11-08 13G BlackRock, Inc. 6.40 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-06-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2023 OR ☐

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 51,668 207,861 24.86
2025-05-08 109,789 283,087 38.78
2025-05-07 54,594 183,089 29.82
2025-05-06 91,876 271,357 33.86
2025-05-05 16,468 70,512 23.35

(click for more detail)

Similar Companies
ATAI – Atai Life Sciences N.V. ATXS – Astria Therapeutics, Inc.
AUPH – Aurinia Pharmaceuticals Inc. AVBP – ArriVent BioPharma, Inc.
AVDL – Avadel Pharmaceuticals plc


Financial data and stock pages provided by
Fintel.io